180 related articles for article (PubMed ID: 37980175)
21. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).
Hes FJ; Feldberg MA
Eur Radiol; 1999; 9(4):598-610. PubMed ID: 10354869
[TBL] [Abstract][Full Text] [Related]
22. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
24. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract][Full Text] [Related]
25. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
26. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.
Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M
Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769
[TBL] [Abstract][Full Text] [Related]
27. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
Meister M; Choyke P; Anderson C; Patel U
Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081
[TBL] [Abstract][Full Text] [Related]
28. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
29. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.
Esteban MA; Harten SK; Tran MG; Maxwell PH
J Am Soc Nephrol; 2006 Jul; 17(7):1801-6. PubMed ID: 16775032
[TBL] [Abstract][Full Text] [Related]
30. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
31. A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.
Cingoz S; van der Luijt RB; Kurt E; Apaydin M; Akkol I; Ozgen MH
Fam Cancer; 2013 Mar; 12(1):111-7. PubMed ID: 23224817
[TBL] [Abstract][Full Text] [Related]
32. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
Petrella BL; Lohi J; Brinckerhoff CE
Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
[TBL] [Abstract][Full Text] [Related]
34. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
35. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
36. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
38. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
[TBL] [Abstract][Full Text] [Related]
40. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
